|
|
 |
|
|
|
Components
| 10X Genomics, Inc. (Class A) |
TXG |
| Accolade, Inc. |
ACCD |
| Adaptive Biotechnologies Corporation |
ADPT |
| Align Technology, Inc. |
ALGN |
| Alphatec Holdings, Inc. |
ATEC |
| American Well Corporation (Class A) |
AMWL |
| Axonics, Inc. |
AXNX |
| Butterfly Network, Inc. |
BFLY |
| CareDx, Inc. |
CDNA |
| Castle Biosciences, Inc. |
CSTL |
| Clover Health Investments, Corp. |
CLOV |
| Cytek Biosciences, Inc. |
CTKB |
| Definitive Healthcare Corp. |
DH |
| DexCom, Inc. |
DXCM |
| Doximity, Inc. (Class A) |
DOCS |
| Establishment Labs Holdings Inc. |
ESTA |
| Exact Sciences Corporation |
EXAS |
| Fulgent Genetics, Inc. |
FLGT |
| Globus Medical, Inc. (Class A) |
GMED |
| GoodRx Holdings, Inc. (Class A) |
GDRX |
| Guardant Health, Inc. |
GH |
| Health Catalyst, Inc. |
HCAT |
| Hims & Hers Health, Inc. |
HIMS |
| Hologic, Inc. |
HOLX |
| Illumina, Inc. |
ILMN |
| Inspire Medical Systems, Inc. |
INSP |
| Insulet Corporation |
PODD |
| Intuitive Surgical, Inc. |
ISRG |
| Invitae Corporation |
NVTA |
| IQVIA Holdings Inc. |
IQV |
| iRhythm Technologies, Inc. |
IRTC |
| LifeStance Health Group, Inc. |
LFST |
| Masimo Corporation |
MASI |
| Morgan Stanley Institutional Liquidity Fund - Treasury Portfolio |
MISXX |
| Myriad Genetics, Inc. |
MYGN |
| Natera, Inc. |
NTRA |
| NeoGenomics, Inc. |
NEO |
| Outset Medical, Inc. |
OM |
| Pacific Biosciences of California, Inc. |
PACB |
| Privia Health Group, Inc. |
PRVA |
| Progyny, Inc. |
PGNY |
| Pulmonx Corporation |
LUNG |
| QIAGEN N.V. |
QGEN |
| QuidelOrtho Corporation |
QDEL |
| ResMed Inc. |
RMD |
| Schrodinger, Inc. |
SDGR |
| SomaLogic, Inc. |
SLGC |
| Tandem Diabetes Care, Inc. |
TNDM |
| Teladoc Health, Inc. |
TDOC |
| TransMedics Group, Inc. |
TMDX |
| Twist Bioscience Corporation |
TWST |
| Veeva Systems Inc. (Class A) |
VEEV |
| Veracyte, Inc. |
VCYT |
|
|
|
|
|
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
|